{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:49:10Z","timestamp":1791571750517,"version":"4.3.4"},"reference-count":9,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["eJHaem"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The real\u2010life retrospective observational study CARMYN aimed at investigating the long\u2010term efficacy and safety of carfilzomib in combination with dexamethasone and lenalidomide (KRd, 159 patients). These patients (62% in first and 38% in second relapse, median age 62 yo) were treated between 02\/2014 and 02\/2017. Most had been pre\u2010exposed to bortezomib (98.2%) and to an IMID (75.4%). At the time of collection, 90% had permanently discontinued carfilzomib. Data collection was conducted from January to July 2021 in 27 participating sites, after a median of 39 months follow\u2010up. For patients treated with KRd, an overall response rate of 78.4% translated in a median progression free survival (PFS) of 24.0 months (95% CI 18.8\u201327.6) and a median overall survival (OS) of 51.1 months (95% CI 41.3\u2013not reached). Results were poorer but difficult to interpret in the small cohort of Kd recipients. The study is one of the longest real\u2010life studies of carfilzomib treatment in patients in first or second relapse. CARMYN confirmed the real\u2010life long\u2010term efficacy of carfilzomib in combination with lenalidomide and dexamethasone with results similar to those of clinical trials. The KRd regimen is thus an option to consider for late relapses in the current context of MM management.<\/jats:p>","DOI":"10.1002\/jha2.828","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T08:12:33Z","timestamp":1702455153000},"page":"55-60","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Real\u2010life effectiveness of carfilzomib in patients with relapsed multiple myeloma receiving treatment in the context of early access: The CARMYN study"],"prefix":"10.1002","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8177-7870","authenticated-orcid":false,"given":"Kamel","family":"Laribi","sequence":"first","affiliation":[{"name":"H\u00e9matologie clinique, CH Le Mans  Le Mans France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9822-4170","authenticated-orcid":false,"given":"Xavier","family":"Leleu","sequence":"additional","affiliation":[{"name":"H\u00e9matologie, CHU de Poitiers  Poitiers France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3749-254X","authenticated-orcid":false,"given":"Nathalie","family":"Texier","sequence":"additional","affiliation":[{"name":"Epid\u00e9miologie, Kappa Sant\u00e9  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Germain","sequence":"additional","affiliation":[{"name":"Epid\u00e9miologie, Kappa Sant\u00e9  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0275-2575","authenticated-orcid":false,"given":"Cyrille","family":"Touzeau","sequence":"additional","affiliation":[{"name":"H\u00e9matologie Clinique, CHU de Nantes, CRCINA, INSERM, CNRS, Universit\u00e9 d'Angers, Universit\u00e9 de Nantes  Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hammoud","sequence":"additional","affiliation":[{"name":"H\u00e9matologie, H\u00f4pital Henri\u2010Mondor AP\u2010HP  Cr\u00e9teil France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Payssot","sequence":"additional","affiliation":[{"name":"H\u00e9matologie Clinique, CHU de Dijon  Dijon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Schulmann","sequence":"additional","affiliation":[{"name":"H\u00e9matologie, CHU de Nancy  Vand\u0153uvre\u2010L\u00e8s\u2010Nancy France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"Le Calloch","sequence":"additional","affiliation":[{"name":"M\u00e9decine Interne, Maladies Infectieuses et Maladies du Sang, CH de Cornouaille  Quimper France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Trebouet","sequence":"additional","affiliation":[{"name":"H\u00e9matologie, CH Bretagne Sud  Lorient France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Driss","family":"Chaoui","sequence":"additional","affiliation":[{"name":"H\u00e9matologie, CH Victor Dupouy  Argenteuil France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selva","family":"David","sequence":"additional","affiliation":[{"name":"H\u00e9matologie, Polyclinique Le Languedoc  Narbonne France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Benbrahim","sequence":"additional","affiliation":[{"name":"H\u00e9matologie Clinique, Nouvel H\u00f4pital d'Orl\u00e9ans  Orl\u00e9ans France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"Benramdane","sequence":"additional","affiliation":[{"name":"H\u00e9matologie, H\u00f4pital Ren\u00e9 Dubos  Pontoise France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Charvet\u2010Rumpler","sequence":"additional","affiliation":[{"name":"H\u00e9matologie, CHRU Jean Minjoz Besan\u00e7on  Besan\u00e7on France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Jadeau","sequence":"additional","affiliation":[{"name":"Plateforme de Recherche Clinique, CH Le Mans  Le Mans France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eglantine","family":"Rouanet","sequence":"additional","affiliation":[{"name":"Plateforme de Recherche Clinique, CH Le Mans  Le Mans France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Decaux","sequence":"additional","affiliation":[{"name":"H\u00e9matologie Clinique, CHU de Rennes  Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0131-8689","authenticated-orcid":false,"given":"Aurore","family":"Perrot","sequence":"additional","affiliation":[{"name":"H\u00e9matologie, CHU de Toulouse, IUC T\u2010Oncopole  Toulouse France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,12,13]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0625"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2018.1437345"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3546-8"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.11.014"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411321"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00464-7"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04158-4"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2820"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04329-3"}],"container-title":["eJHaem"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jha2.828","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T16:48:12Z","timestamp":1708706892000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jha2.828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,13]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1002\/jha2.828"],"URL":"https:\/\/doi.org\/10.1002\/jha2.828","archive":["Portico"],"relation":{},"ISSN":["2688-6146","2688-6146"],"issn-type":[{"value":"2688-6146","type":"print"},{"value":"2688-6146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,13]]},"assertion":[{"value":"2023-09-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}